Literature DB >> 21824552

The epidemiology of sarcopenia.

Ian Janssen1.   

Abstract

The term sarcopenia was coined in 1989 and refers to the age-related loss in skeletal muscle mass. Operational definitions of sarcopenia have been used in research studies to identify older persons with healthy muscle mass values (normal) and older adults with unacceptably low muscle mass values (sarcopenic). Despite the enormous research on sarcopenia that has been completed in the past 20 years, sarcopenia currently receives little attention in the clinical setting. To address this issue, the European Working Group on Sarcopenia in Older People recently developed a consensus definition of sarcopenia. The availability of a consensus definition may assist with the integration of sarcopenia into mainstream geriatric assessment.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21824552     DOI: 10.1016/j.cger.2011.03.004

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  41 in total

1.  The Impact of Dietary Protein or Amino Acid Supplementation on Muscle Mass and Strength in Elderly People: Individual Participant Data and Meta-Analysis of RCT's.

Authors:  M Tieland; R Franssen; C Dullemeijer; C van Dronkelaar; H Kyung Kim; T Ispoglou; K Zhu; R L Prince; L J C van Loon; L C P G M de Groot
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

Review 2.  Fall and Fracture Risk in Sarcopenia and Dynapenia With and Without Obesity: the Role of Lifestyle Interventions.

Authors:  David Scott; Robin M Daly; Kerrie M Sanders; Peter R Ebeling
Journal:  Curr Osteoporos Rep       Date:  2015-08       Impact factor: 5.096

Review 3.  Nutritional supplements in support of resistance exercise to counter age-related sarcopenia.

Authors:  Stuart M Phillips
Journal:  Adv Nutr       Date:  2015-07-15       Impact factor: 8.701

4.  Association of milk consumption frequency on muscle mass and strength: an analysis of three representative Korean population studies.

Authors:  Yu-Jin Kwon; Ji-Won Lee; Jun-Hyuk Lee; Hye Sun Lee; Hyungmi Kim
Journal:  Eur J Nutr       Date:  2019-12-19       Impact factor: 5.614

Review 5.  Atrogin-1, MuRF-1, and sarcopenia.

Authors:  Jonathan P Gumucio; Christopher L Mendias
Journal:  Endocrine       Date:  2012-07-20       Impact factor: 3.633

6.  Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study.

Authors:  Adriana Villaseñor; Rachel Ballard-Barbash; Kathy Baumgartner; Richard Baumgartner; Leslie Bernstein; Anne McTiernan; Marian L Neuhouser
Journal:  J Cancer Surviv       Date:  2012-10-04       Impact factor: 4.442

Review 7.  Malnutrition in Older Adults with Cancer.

Authors:  Xiaotao Zhang; Beatrice J Edwards
Journal:  Curr Oncol Rep       Date:  2019-07-29       Impact factor: 5.075

8.  Primary Sarcopenia in Older People with Normal Nutrition.

Authors:  S Yadigar; H Yavuzer; S Yavuzer; M Cengiz; M Yürüyen; A Döventaş; D S Erdinçler
Journal:  J Nutr Health Aging       Date:  2016-03       Impact factor: 4.075

9.  Incidence of sarcopenia and dynapenia according to stage in patients with idiopathic Parkinson's disease.

Authors:  Tamer Yazar; Hülya Olgun Yazar; Emel Zayimoğlu; Soner Çankaya
Journal:  Neurol Sci       Date:  2018-05-12       Impact factor: 3.307

10.  Prevalence of sarcopenia and associated factors among Thai population.

Authors:  Chatlert Pongchaiyakul; Panita Limpawattana; Praew Kotruchin; Rajata Rajatanavin
Journal:  J Bone Miner Metab       Date:  2013-02-02       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.